SCHEMBL23072069

SCHEMBL23072069

CC[C@]1(CO)O[C@@H](c2cnc3cnc(N)nn23)[C@H](F)[C@@H]1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15257356 0.83 — —
SCHEMBL18776490 0.82 — —
SCHEMBL15257346 0.78 — —
SCHEMBL15257378 0.78 CSNK1D (0.30) —
SCHEMBL15259024 0.77 STING1 (0.30) —
SCHEMBL15259042 0.76 — —
SCHEMBL18193387 0.76 — —
SCHEMBL15257372 0.74 — —
SCHEMBL15257326 0.74 — —
SCHEMBL18193388 0.74 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10941177-B2 2′-substituted carba-nucleoside analogs for antiviral treatment GILEAD SCIENCES, INC. (US) 2021-03-09 — — US disclosed
Send feedback